Tango Therapeutics, Inc. · NASDAQ:TNGX
TCG Crossover GP II, LLC reported a 7.00% stake in Tango Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
TCG Crossover GP II, LLC reported a 7.00% stake in Tango Therapeutics, Inc., 10,147,867 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 7.00%
- Shares
- 10,147,867
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TCG Crossover GP II, LLC | 7.00% | 10,147,867 |
| TCG Crossover Fund II, L.P. | 7.00% | 10,147,867 |
| Chen Yu | 7.00% | 10,147,867 |
Source
Related
- Tango Therapeutics, Inc.
- TCG Crossover GP II, LLC
- Tango Therapeutics, Inc. shareholders
- Schedule 13G/A · TCG Crossover GP II, LLC · May 15, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Feb 17, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Nov 14, 2025
- Form 4 · Crystal Adam · Oct 5, 2026
- Form 4 · Newcomb Jessica · Sep 24, 2026
- Form 4 · Crystal Adam · Sep 3, 2026
- Schedule 13G · Goldman Sachs Group Inc · Aug 14, 2026
- Schedule 13G/A · Nextech Crossover I GP S.a. r.l. · Aug 14, 2026